Jump to main content
Jump to site search

All chapters
Previous chapter Next chapter


Monoaminergic Approaches for Treatment of Schizophrenia

Since the discovery of haloperidol in the 1950s, monoaminergic receptors have provided a number of potential targets for treatment of schizophrenia. This chapter will survey the profiles of existing dopaminergic-based antipsychotic drugs and review recent medicinal chemistry approaches that engage other monoaminergic receptors to discover novel agents for treatment of schizophrenia. In addition to single-target approaches, attempts to discover molecules that interact selectively (i.e. designed to bind) with more than a single receptor to provide effective antipsychotic agents will be reviewed. These efforts highlight attempts to address unmet needs with existing therapy, including efficacy in a broader range of patients of this complex and debilitating disease.

Publication details

Print publication date
02 Nov 2012
Copyright year
Print ISBN
From the book series:
Drug Discovery